Search Result
| 1 |
Regulatory mechanism of lncRNA miR143HG in miR-504 and its effect on proliferation and apoptosis of non-small cell lung cancer cells
Abstract |
 Fulltext
|
| 2 |
Effectiveness of nab-paclitaxel versus traditional paclitaxels in the treatment of ovarian cancer
Abstract |
Fulltext
|
| 3 |
Preparation, characterization and stability of silver sulfadiazine nanoliposomes
Abstract |
Fulltext
|
| 4 |
Niacin downregulates chemokine (c-c motif) ligand 2 (CCL2) expression and inhibits fat synthesis in rat liver cells
Abstract |
Fulltext
|
| 5 |
Paclitaxel liposomes exert radio-sensitization effect on breast cancer cell line SK-BR-3 by regulating expressions of apoptotic proteins
Abstract |
Fulltext
|
| 6 |
Apoptotic effect of astaxanthin from white shrimp shells on lung cancer A549 cells
Abstract |
Fulltext
|
| 7 |
Characterization, purity assessment, and preparation of liposomal formulation of 2,4,6-trihydroxygeranylaceto-phenone
Abstract |
Fulltext
|
| 8 |
Comparison of classical, stealth and super-stealth liposomes for intravenous delivery of lumefantrine: Formulation, characterization and pharmacodynamic study
Abstract |
Fulltext
|
| 9 |
Evaluation of clinical effectiveness of paclitaxel and ursolic acid co-loaded liposomes as enhanced treatment for head and neck squamous cell carcinoma
Abstract |
Fulltext
|
| 10 |
Induction of apoptosis in response to improved gedunin by liposomal nano-encapsulation in human non-small-cell lung cancer (NCI-H292) cell line
Abstract |
Fulltext
|
| 11 |
Inhibition of telomerase activity and cell growth by free and nanoliposomal forms of punicalagin in human leukemia cell line K562
Abstract |
Fulltext
|
| 12 |
Evaluation of immunomodulatory effect of immunace on adjuvanticity of 1,2-dioleoyl-3-trimethylammoniumpropane-based liposomes
Abstract |
Fulltext
|
| 13 |
Formulation of a new generation of liposomes from bacterial and archeal lipids
Abstract |
Fulltext
|
| 14 |
Formulation and evaluation of analgesic activity of polysorbate 80-coated loperamide liposomes in mice
Abstract |
Fulltext
|
| 15 |
Cytotoxicity of nanoliposomal cisplatin coated with synthesized methoxypolyethylene glycol propionaldehyde in human ovarian cancer cell line A2780CP
Abstract |
Fulltext
|
| 16 |
Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy
Abstract |
Fulltext
|
| 17 |
Preparation and characterization of nanoliposomal beta-cryptoxanthin and its effect on proliferation and apoptosis in human leukemia cell line K562
Abstract |
Fulltext
|
| 18 |
Avanafil liposomes as transdermal drug delivery for erectile dysfunction treatment: Preparation, characterization, and in vitro, ex vivo and in vivo studies
Abstract |
Fulltext
|
| 19 |
Effect of cytotoxicity of pegylated liposomal recombinant human erythropoietin-alfa on neuroblastoma cell line SH-SY5Y
Abstract |
Fulltext
|
| 20 |
Characterization of Diclofenac Liposomes Formulated with Palm Oil Fractions
Abstract |
Fulltext
|
| 21 |
Investigation of Galactosylated Low Molecular Weight Chitosan-Coated Liposomes for Cancer Specific Drug Delivery
Abstract |
Fulltext
|
| 22 |
Pegylation of Nanoliposomal Paclitaxel Enhances its Efficacy in Breast Cancer
Abstract |
Fulltext
|
| 23 |
Anti-HIV Effect of Liposomes Bearing CXCR4 Receptor Antagonist N15P
Abstract |
Fulltext
|
| 24 |
Impact of Nanoparticles on Cancer Therapy
Abstract |
Fulltext
|
| 25 |
Evaluation of the Photostability and Photodynamic Efficacy of Rose Bengal Loaded in Multivesicular Liposomes
Abstract |
Fulltext
|
| 26 |
Life is based on a combination of biochemistry and bioencapsulation
Abstract |
Fulltext
|
26 matching items found
|
Archives
| 2025; 24: |
1,
2,
3.
|
| 2024; 23: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2023; 22: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2022; 21: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2021; 20: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2020; 19: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2019; 18: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2018; 17: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2017; 16: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2016; 15: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2015; 14: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2014; 13: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
| 2013; 12: |
1,
2,
3,
4,
5,
6.
|
| 2012; 11: |
1,
2,
3,
4,
5,
6.
|
| 2011; 10: |
1,
2,
3,
4,
5,
6.
|
| 2010; 9: |
1,
2,
3,
4,
5,
6.
|
| 2009; 8: |
1,
2,
3,
4,
5,
6.
|
| 2008; 7: |
1,
2,
3,
4.
|
| 2007; 6: |
1,
2,
3,
4.
|
| 2006; 5: |
1,
2.
|
| 2005; 4: |
1,
2.
|
| 2004; 3: |
1.
|
| 2003; 2: |
1,
2.
|
| 2002; 1: |
1,
2.
|
|
